← Eichor
Study identifier: NCT06920563 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Remote Postpartum Blood Pressure Monitoring and Cardiovascular Education

Condition: Pre-Eclampsia; Complicating Pregnancy · Gestational Hypertension  ·  Sponsor: Ochsner Health System

PhaseNA
Planned participants296
Who can joinFemale, 18 Years to no upper limit
Healthy volunteersNo

About this study

The goal of this clinical trial is to learn if patient education and regular text reminders are a feasible intervention to engage patients and reduce post partum hypertension. The main questions it aims to answer are: Is a structured postpartum remote blood pressure monitoring intervention with education and individualized medication initiation/adjustment follow-up by televisit feasible? Does a structured program reduce the occurrence of postpartum hypertension, ED visits, hospital readmissions, and adverse outcomes? Participants will: View an educational video on HDP post-delivery Receive 1-2 times daily text messages for 6 weeks postpartum Have their blood pressure medications adjusted to lower targets post partum

This description comes directly from the study's public registry record.

Talk to the study team

Salima Qamruddin, MD  ·  +1 (504) 842-4135  ·  salima.qamruddin@ochsner.org

Always discuss trial participation with your own doctor first.

Locations (1)

Ochsner BaptistNew Orleans, Louisiana, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06920563